| Product Code: ETC13350036 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Rapid Influenza Diagnostic Test Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Rapid Influenza Diagnostic Test Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Rapid Influenza Diagnostic Test Market Revenues & Volume, 2021 & 2031F |
3.3 North America Rapid Influenza Diagnostic Test Market - Industry Life Cycle |
3.4 North America Rapid Influenza Diagnostic Test Market - Porter's Five Forces |
3.5 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By Mode of Testing, 2021 & 2031F |
3.10 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 North America Rapid Influenza Diagnostic Test Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Rapid Influenza Diagnostic Test Market Trends |
6 North America Rapid Influenza Diagnostic Test Market, 2021 - 2031 |
6.1 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Digital RIDT, 2021 - 2031 |
6.1.3 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Traditional RIDT, 2021 - 2031 |
6.1.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Visual Read RIDT, 2021 - 2031 |
6.1.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Automated RIDT, 2020 - 2028 |
6.1.6 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Others, 2020 - 2028 |
6.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Lateral Flow, 2021 - 2031 |
6.2.3 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Immunoassay, 2021 - 2031 |
6.2.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By ELISA, 2021 - 2031 |
6.2.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By PCR-Based, 2021 - 2031 |
6.3 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.3.3 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Research Institutions, 2021 - 2031 |
6.3.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.6 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Mode of Testing, 2021 - 2031 |
6.4.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Point-of-Care, 2021 - 2031 |
6.4.3 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Self-Testing, 2021 - 2031 |
6.4.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Professional Use, 2020 - 2028 |
6.4.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By OTC Testing, 2020 - 2028 |
6.4.6 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Others, 2020 - 2028 |
6.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Sample Type, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Nasopharyngeal Swab, 2020 - 2028 |
6.5.3 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Throat Swab, 2020 - 2028 |
6.5.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Nasal Aspirate, 2020 - 2028 |
6.5.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Saliva Sample, 2020 - 2028 |
6.5.6 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Others, 2020 - 2028 |
7 North America Rapid Influenza Diagnostic Test Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Rapid Influenza Diagnostic Test Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Rapid Influenza Diagnostic Test Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Rapid Influenza Diagnostic Test Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Mode of Testing, 2021 - 2031 |
7.5.1 United States (US) Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Mode of Testing, 2021 - 2031 |
7.5.2 Canada Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Mode of Testing, 2021 - 2031 |
7.5.3 Rest of North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Mode of Testing, 2021 - 2031 |
7.6 North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6.1 United States (US) Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6.2 Canada Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6.3 Rest of North America Rapid Influenza Diagnostic Test Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
8 North America Rapid Influenza Diagnostic Test Market Key Performance Indicators |
9 North America Rapid Influenza Diagnostic Test Market - Export/Import By Countries Assessment |
10 North America Rapid Influenza Diagnostic Test Market - Opportunity Assessment |
10.1 North America Rapid Influenza Diagnostic Test Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Rapid Influenza Diagnostic Test Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Rapid Influenza Diagnostic Test Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Rapid Influenza Diagnostic Test Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Rapid Influenza Diagnostic Test Market Opportunity Assessment, By Mode of Testing, 2021 & 2031F |
10.6 North America Rapid Influenza Diagnostic Test Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
11 North America Rapid Influenza Diagnostic Test Market - Competitive Landscape |
11.1 North America Rapid Influenza Diagnostic Test Market Revenue Share, By Companies, 2022 |
11.2 North America Rapid Influenza Diagnostic Test Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here